The Usefulness of 99m Tc Diethylenetriamine Pentaacetate (DTPA) or Mercaptoacetyltriglycine (MAG3) Renal Perfusion Scan in Assessing Chronic Renal Complications of COVID-19

AuthorHadi Maleken
AuthorRaheleh Hedayatien
AuthorMohamadjavad Yasemien
Issued Date2023-01-03en
AbstractBackground: Imaging departments worldwide are exploring different ways to help manage chronic complications of COVID-19 after two years. Objectives: Renal complications following acute kidney injury in the acute phase of COVID-19 or exacerbation of chronic kidney disease (CKD) are crucial. Methods: This article presented the role of 99m Tc diethylenetriamine pentaacetate (DTPA) or mercaptoacetyltriglycine (MAG3) renal perfusion scan in managing chronic renal complications following COVID-19 by submitting the relevant techniques and available radiopharmaceuticals. Results: Renal perfusion scan with 99m Tc DTPA and MAG3 could evaluate profusion and function in acute and chronic settings and manage these renal complications. Conclusions: Based on the results, 99m Tc DTPA or MAG3 renal perfusion scan could detect, monitor, and evaluate response to treatment in COVID-19-related renal chronic damages and complications.en
DOIhttps://doi.org/10.5812/jhrt-122894en
KeywordCOVID-19en
KeywordRenal Complicationsen
KeywordDTPA Renal Scanen
KeywordAcute Kidney Injuryen
PublisherBrieflandsen
TitleThe Usefulness of 99m Tc Diethylenetriamine Pentaacetate (DTPA) or Mercaptoacetyltriglycine (MAG3) Renal Perfusion Scan in Assessing Chronic Renal Complications of COVID-19en
TypeBrief Reporten

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
jhrt-9-1-122894.pdf
Size:
77.66 KB
Format:
Adobe Portable Document Format
Description:
Article/s PDF